Key facts
- This page summarizes Mark A. Baumgartner's Form 4 filing for Physicians Realty Trust.
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2022, 15:05.
Mark A. Baumgartner - 01 Mar 2022 Form 4 Insider Report for Physicians Realty Trust
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2022, 15:05:30 UTC
- Next SEC filing
- 03 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher M. Bartoli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark A. Baumgartner filed Form 4 for Physicians Realty Trust on 03 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +2,906
- Change %
- +6.2%
- Price
- Shares after
- 49,660
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Mark A. and Mary Jane Baumgartner Revocable Trust dated 09/16/07.
- Footnotes
- F1
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +2,590
- Change %
- +5.2%
- Price
- Shares after
- 52,250
- Date
- 02 Mar 2022
- Ownership
- Represents shares held by the Mark A. and Mary Jane Baumgartner Revocable Trust dated 09/16/07.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DOC
transaction
Derivative
2021 Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -2,906
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 2,905
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Mark A. and Mary Jane Baumgartner Revocable Trust dated 09/16/07.
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 2,906
- Exercise price
- Footnotes
- F2
DOC
transaction
Derivative
2022 Restricted Share Unit Grant
Award
- Transaction value
- $0
- Shares
- +6,720
- Change %
- Price
- $0.000000
- Shares after
- 6,720
- Date
- 01 Mar 2022
- Ownership
- Represents shares held by the Mark A. and Mary Jane Baumgartner Revocable Trust dated 09/16/07.
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 6,720
- Exercise price
- Footnotes
- F3
DOC
transaction
Derivative
2020 Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -2,590
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 Mar 2022
- Ownership
- Represents shares held by the Mark A. and Mary Jane Baumgartner Revocable Trust dated 09/16/07.
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 2,590
- Exercise price
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of the Issuer's common shares.
Footnote F2
March 1, 2021, the Reporting Person was granted 5,811 restricted stock units, which vest in two equal installments on March 1, 2022 and March 1, 2023, subject to the terms of the grant. Each restricted stock unit represents the right to receive one share of the Issuer's common shares.
Footnote F3
March 1, 2022 grant of restricted stock units under the Issuer's 2013 Equity Incentive Plan, which will vest in two equal annual installments on March 1, 2023 and March 1, 2024, subject to the terms of the grant. Each restricted stock unit represents the right to receive one share of the Issuer's common shares.
Footnote F4
March 2, 2020, the Reporting Person was granted 5,181 restricted stock units, which vest in two equal installments on March 2, 2021 and March 2, 2022, subject to the terms of the grant. Each restricted stock unit represents the right to receive one share of the Issuer's common shares.